Hungary Richter to report record revenue on weak forint

Analysts expect strong Q3 figures

Richter to expand use of its drug for therapeutic purposes

For women suffering from endometriosis

Hungary Richter divests Romanian subsidiary

Wholesale and retail too

Cutting-edge gene therapy arrive in Hungary too - Interview with the CEO of Novartis Hungária

Matt Zeller in the house

Hungary Richter signs deal on distribution of Evra in Canada

With Searchlight Pharma Inc.

Richter posts record quarterly revenue, profit, faces uncertainties in Russia, Ukraine

Robost performance in Q4 2021

Richter to enter U.S. market with new drug

Signs license agreement with Hikma

Hungary Richter keeps breaking records

Revenue and after-tax profit at never-before-seen levels in Q3

Hungary’s Richter decides on mandatory vaccination

Management ups guidance after strong Q3

Hungry gov’t does away with yet another market

Online drug purchases to be outlawed

Leading packaging group delivers HUF 6.5 billion plant expansion in Hungary

Minister announces investments

National Asset Management influence in Richter ceases

Transferred to National health and Education of Medical Doctors

Hungary’s Richter surprises analysts with record Q2 result (3)

EU inks deal for supply of potential coronavirus drug

With GlaxoSmithKline

European Commission greenlights new Richter drug

Ryeqq granted marketing authorisation

Hungary May industrial output up 3.4% from April

Grows 40% year on year

Richter sells wholesale, retail operations in Moldova

Will receive 62% of price as majority owner

Hungary Richter issues HUF 70 bn bond

In scope of central bank programme

Hungary’s Richter extends licensing agreement with AbbVie

Cariprazine to be sold in more countries

Hungary Richter to issue up to HUF 70 billion worth of bonds

It would be one of the largest issuances in the central bank's programme